Genomics Market By Product & Services Type (Products, Services), By Application Type (Disease Diagnostics, Drug Discovery, Personalized Medicine, Agriculture And Animal Research, Other), By End-User Type (Academic And Government Research, Hospitals & Clinics, Biopharmaceutical Companies, Clinical Research) - Growth, Share, Opportunities & Competitive Analysis, 2018 – 2026

$ 4325

The global genomics market held US$ 13,122.9 Mn in 2017 and expected to grow at compound annual growth rate (CAGR) of 10.4% during the forecast period from 2018 to 2026. The exploration of genomics has surpassed in the last three decades to massive advancements in the technology that allowed the researchers to sequence larger pieces of genome.

Cell Proliferation Kits Market - Growth, Future Prospects & Competitive Analysis, 2018-2026

$ 4325

Cell proliferation kits are assay based test solutions that aid in the quantification of cell proliferation and viability. Proliferation tests are based on the division of tetrazolium salt WST-1 to formazan by the activity of cellular mitochondrial dehydrogenases.

Biologics Market By Product (Recombinant Therapeutic Proteins, Blood & Blood Components, Cellular & Gene Therapy, Vaccines), By Disease (Oncology, Autoimmune Diseases, Diabetes, Infectious Diseases, Others) - Growth, Future Prospects & Competitive Analysis, 2018 - 2026

$ 4325

Global biologics market accounted for market value of US$ 254.9 Bn in 2017 and expected to attain US$ 580.5 Bn by 2026. Recombinant therapeutic proteins contributed largest market share in 2017 while cellular and gene therapies exhibited fastest annual growth during the forecast period from 2018 to 2026.

Life Science Microscopy Devices Market By Device Type (Optical (Light) Microscopy Devices, Electron Microscopy Devices, Scanning Probe Microscopy Devices), By Application Type (Microbiology, Cell Biology, Bioengineering, Pathology, Neuroscience, Pharmacology, Toxicology) - Growth, Future Prospects And Competitive Analysis, 2017 - 2025

$ 4325

Microscopy plays a central role in the field of life science in order to observe biological structure. It successfully allows to expand its usage in various domain of life science to get a magnified version of objects. The wide range of microscopy device varies in terms of degree of magnification, image resolution and the technology involved. The necessity of microscope is to gain a clear picture of biological structure in terms of diagnosis and treatment of any medical condition. Microscopy devices contributes significantly in the recent developments of drug discovery to cure diseases and to enhance quality of life.

Immunohistochemistry Market By Product (Antibodies, Equipment, Reagents, Kits), By Application (Diagnostics, Drug Testing) - Growth, Future Prospects, And Competitive Analysis, 2017 - 2025

$ 4325

The most common application of immunohistochemistry is to study and identify the site of origin of metastatic tumor when the primary site has already been identified. Technological advancement in the panel of immunostains can be helpful in resolving all diagnostic problems. Recent antibodies such as cadherin-17, SATB2, CDX-2 and villin have found application in the differential diagnosis of suspected metastatic adenocarcinoma.

Industrial Microbiology Market By Products (Equipment And Systems, Reaction Consumables, Laboratory Supplies), By Test Type (Sterility Testing, Microbial Limits Testing, Bio-Burden Testing, Other Test), By End-Users (Preface, Pharmaceutical And Biotechnology, Food And Beverages, Agriculture And Environment, Personal Care Products) - Growth, Share, Opportunities & Competitive Analysis, 2017 - 2025

$ 4325

Industrial microbiology refers to screening of microorganisms for production of pharmaceuticals, food and beverage, personal care products and other applications. The industrial microbiology market is significantly large and is perpetually growing. Industries worldwide perform billions of tests every year thus representing substantial market potential.

Bacteriophage Market By Product Type (dsDNA Bacteriophage, ssDNA Bacteriophage, ssRNA Bacteriophage), By Application (Clinical Application, Food & Beverages, Phage Display, Phage Therapy, Environmental Application, Veterinary) - Growth, Future Prospects & Competitive Analysis, 2018 – 2026

$ 4325

The global bacteriophage market held US$ 567.9 Mn in 2017 and expected to grow at compound annual growth rate (CAGR) of 3.9% during the forecast period from 2018 to 2026. Bacteriophages are estimated as the most widely distributed and varied entities in the biosphere. From the initial research that defined the nature of viruses, bacteriophages have become model organisms for understanding the biochemistry.

Life Science Instrumentation Market By Technology (Spectroscopy, Chromatography, Polymerase Chain Reaction, Next Generation Sequencing, Clinical Chemistry Analyzers, Flow Cytometry and Immunoassays), By End User (Research Institutes, Pharmaceutical & Biotechnology Companies and Diagnostic Laboratories) - Growth, Future Prospects & Competitive Analysis, 2019 – 2027

$ 4325

The life science instrumentation market is set to reach US$ 100,792.7 Mn by 2027 from US$ 57,185.5 Mn in 2018 showcasing moderate growth at a compounded annual growth rate (CAGR) of 6.5% during the forecast period from 2019 to 2027. Technological advancement in the life science instruments and stringent healthcare norms pertaining to food and drug manufacturing process drive the market growth for life science instrumentation techniques. Rising public health awareness and proactive government policies to curb the mortality associated with chronic diseases further propel the demand for life science instrumentation technology in the pharmaceutical and biotechnology companies.

Cell Expansion Market By Product (Instruments, Consumables and Disposables), By Application (Regenerative Medicine, Cancer & Stem Cell Research, Clinical Diagnostics and Others) - Growth, Future Prospects & Competitive Analysis, 2019 – 2027

$ 3800

The cell expansion market is set to reach from US$ 9,743.7 Mn in 2018 to US$ 33,443.2 Mn by 2027 at a compound annual growth rate (CAGR) of 15.0% during the forecast period from 2019 to 2027. Lack of effective treatment regime for the chronic disease has resulted in significant rise in novel drug discovery and development research studies throughout the globe. Increasing demand for regenerative medicine and stem cell therapy further consolidates the cell expansion market growth.

Immune Repertoire Sequencing Market By Cancer Product Type (Assay Kits, Instruments), By Application (Cancer Immunotherapy, Biomarker Discovery, Autoimmune Diseases, Vaccine Development And Efficacy, Infectious Diseases, Others), By End-User (Diagnostic Labs, Biotechnology And Pharmaceutical Companies, Academic And Research Institutes, Others) - Industry Size, Growth, Share And Forecast To 2026

$ 3800

Immune Repertoire Sequencing refers to novel approach to next generation sequencing that helps to understand and examine immune mediated diseases. The Global market for Immune Repertoire Sequencing is expected to witness a substantial growth, growing at a CAGR of approximately 8% over the forecast period of 2019-2026. Immune repertoire sequencing is among the most accurate and sensitive platform for the profiling of antigen specific information within lymphocytes. The main advantage with this technique is that it is minimally invasive in nature and requires low amount of sample. The market for Immune repertoire sequencing is primarily driven by growing prevalence of cancer, growing research in the field of immunotherapy along with growing pharmaceutical R&D expenditure.

Rat Model Market By Application (Immunology and Inflammation, Oncology, Toxicology, Diabetes, Others), By Type (Outbred rats , Conditioned/surgically modified rats, Inbred rats, Hybrid/Congenic rats, Knockout/genetically engineered rats, Immunodeficient rats), By Service (Genetic testing, Rederivation, Quarantine, Breeding, Cryopreservation, Other), By Technology (Microinjection, Embryonic Stem Cells, Nuclear Transferase, Others), Industry Size, Growth, Share And Forecast To 2022

$ 3800

The global rat model market is growing at an impressive CAGR of 9.9% during the forecast period and the revenue is estimated to grow approximately $727.45 million by 2022. There has been a rise in the advancements in the gene editing tools, which is expected to be triggering the growth of global rat model market. Steady increase in the number of neurodegenerative, immunology and oncology disorders is anticipated to propel the growth of global rate model market in the next few years.

Polymeric Nanoparticles Market By Application (Electronics, Automotive, Coatings, Packaging, Aerospace & Defence), By Type (Nanoclay, Carbon Nanotubes, Nanofiber, Metal Oxide), Industry Size, Growth, Share And Forecast To 2022

$ 3800

The global polymeric nanoparticles market is estimated to grow at an impressive rate during the forecast period of 2016-2022. Polymer nanoparticles have attracted mostly the research groups and are being used in a rising number of areas during the last years. Naturally, two prime strategies are applied for their preparation: the polymerization of monomers and the dispersion of preformed polymers.

Regenerative Medicine Market By Technology (Small Molecules And Biologics, Gene Therapy, Cell Therapy), By Application (Dermatology, Cardiovascular Disorders, Central Nervous System (CNS), Orthopedic, Dental), Industry Size, Growth, Share And Forecast To 2022

$ 3800

The regenerative medicine market is expected to grow with a robust CAGR of 14% in the forecast period of 2016 to 2022. In 2015, the market has generated the revenue of $ 3.85 billion and is expected to reach up to $9.64 billion by 2022. The fast growing advancements in stem cell technology; thepotentialsof nanotechnology; and,rising cases of chronic diseases and trauma injuriesare the major drivers for the regenerative medicine,globally.The increasing demand and awareness of steam cells also helps to increase themarket forregenerative medicine.

Companion Diagnostics Market By Application (Colorectal Cancer Diagnostics, Breast Cancer Market, Lung Cancer, Melanoma, Urology, Gastric Cancer), By Technology (Polymerase Chain Reaction (PCR) Market, Situ Hybridization (ISH) Market, Immunohistochemistry (IHC) Market), By End User (Pharmaceutical Companies, Reference Labs), Industry Size, Growth, Share And Forecast To 2022

$ 3800

According to the FDA,”the companion diagnostic device is a medical device, often an in vitro device, which provides information that is essential for the safe and effective use of a corresponding drug or biological product. The test helps a health care professional determine whether a particular therapeutic product’s benefits to patients will outweigh any potential serious side effects or risks”.

3D Cell Culture Market By Application (Cancer Cell Research, Cell Based Assays/Toxicity Screening, Regenerative Medicine/Tissue Engineering, In Vivo Applications For Stem Cells, 3D Printing/Microfluidics), By Technology (Scaffold Based, Scaffold Free), By End User (Biotechnology And Pharmaceutical Industries, Research Laboratories, Hospitals And Diagnostic Centers), Industry Size, Growth, Share And Forecast To 2022

$ 3800

The global 3D cell culture market has been expected to grow at the CAGR of 24.7% during 2016-2022. Growing prevalence rate of cancer is the major driver of 3D cell culture market. 3D cell culture has been anticipated to witness commercialization over the forecasted period due to various factors that are positively boosting the market such as adoption of green initiatives, improving energy efficiency, supportive government legislation and so on.

Next Generation Sequencing Market By Technology (Whole Genome Sequencing, Targeted Resequencing, RNA Sequencing, Chip Sequencing, De Novo Sequencing), By Applications (Oncology, Genetic Screening, Infectious Diseases Drug And Biomarker Discovery, Agriculture & Animal Research, Idiopathic Diseases) - Growth, Future Prospects And Competitive Analysis 2016 - 2025

$ 4325

Next generation sequencing is a high-throughput sequencing that enables sequencing and assembling of number of short DNA reads at a small period of time and with a better accuracy. Next-generation sequencing (NGS) technologies have progressive advantages in terms of cost-effectiveness, unprecedented sequencing speed, high resolution and accuracy in genomic analyses. 

Microbial Product Technology Market By Product (Agriculture, Energy, Healthcare, Manufacturing), By End User Application, , Industry Size, Growth, Share And Forecast To 2022

$ 3800

The global microbial product technology market is expected to grow with a CAGR of 15.1% during the forecasted period 2015-2022. The major factors contributing towards the growth in market isescalating incidences of infectious diseases in the global market. The demand for microbial product is mainly attributed from agriculture industry, as the agriculture industry has been estimated to grow with an eye popping CAGR in the forecasted period.The growth in agriculture industry is mainly driven by the increasing demand for organic products in the global market.

Next Generation Cancer Diagnostics Market By Technology (Lab-On-A-Chip, Dna Microarrays, Multiplexed Assays, Multiplexed Assays, Rt-Pcr & Multiplexing, Protein Microarrays, Cellular Capture And Identification, Next Generation Sequencing, Benchtop Sequencers), By Cancer Type (Sex-Related Tumors, Blood-Born Cancers, Lung Cancer, Solid Tumors, Colorectal Cancer), By Function (Prognosis Diagnostics, Companion Diagnostics, Cancer Screening, Risk Analysis, Therapeutic Monitoring) By Applications (Proteomic Analysis, Epigenetic Analysis, Genetic Analysis, Biomaker Development, Ctc Analysis), Industry Size, Growth, Share And Forecast To 2022

$ 3800

The global next generation cancer diagnostics market was estimated to be around $2.95 billion in 2015 and is forecasted to reach around $20.93 billion at a CAGR of 32.30% during 2015-2022. The major factors that drive this global next generation cancer diagnostics market is the rising number of chronic diseases like lung cancer, solid cancer etc. along with rising geriatric population which helps in boosting the growth of the next generation cancer diagnostics market in next 6 to 7 years.

Oncology Based Molecular Diagnostics Market By Type (Breast Cancer, Prostate Cancer, Colorectal Cancer, Cervical Cancer, Liver Cancer, Lung Cancer, Blood Cancer, Kidney Cancer), By Product (Instruments, Reagents), By Test Location (Clinics And Other Establishments, Point Of Care), By Technology (PCR, Transcription Mediated Amplification, Situ Hybridization, Sequencing, Isothermal Nucleic Acid Amplification Technology, Chips And Microarrays), Industry Size, Growth, Share And Forecast To 2022

$ 3800

The global oncology molecular diagnostics market has contributed $1139.5 million in 2014 and it is expected to grow around $3391 million at the CAGR of 15% during 2015-2022. The major factors that drives the global oncology molecular diagnostics market are increasing demand for molecular diagnostic devices due to the increasing number of cancer patients all over the world.

DNA Testing Market By Product Type (Instruments, Reagents), By Technology (PCR, Microarrays, Sequencing Technology, Mass Spectrometry),By Application (Oncology, Infectious Disease Testing, Clinical Diagnosis Confirmation, Prenatal Diagnosis), By End Users (Point Of Care, Central Laboratories), Industry Size, Growth, Share And Forecast To 2022

$ 3800

The global DNA testing market is expected to grow at the CAGR of 9.9% during 2015-2022. The major factors driving the market are increasing chronic and infectious diseases, growing point of care centers and technological advancement. With the growing infectious and chronic diseases the need for DNA testing is increasing rapidly resulting in growth of the market.

Biotechnology

The use of a living organism to change a process or end product is what the broad spectrum of biotechnology.

Biotechnology has been the cause of many inventions and innovations that can be categorized as  products and processes. Products include agriculture, food technology,  pharmaceuticals, stem cell technology. US and Japan have filed the largest number of patents in biotechnology leading the global industry.

Our reports help identify key industry statistics and trends. Brisk Insights focuses on important performance geographies and competitive analysis.